跳至主要内容
临床试验/NCT02193035
NCT02193035已完成不适用

Microparticles as an Inflammatory Marker in Severe Aortic Stenosis.

InCor Heart Institute2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2014年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
2
主要终点
Difference in microparticle levels

研究概览

简要总结

Microparticles are small cell fragments that can induce fat plaques, calcification and formation of thrombus. They can be released through multiple stimulations, but also the high flow of blood through partially obstructed aortic valves.

In patients with severely obstructed aortic valves the investigators hypothesize that microparticles levels will be elevated and that they will go down after percutaneous treatment of the valves.

详细描述

Microparticle (MPs) levels and subtypes according to endothelial cell, macrophage and platelet markers will be measured by flow-cytometry using appropriate fluorochromes. Patient baseline (including measures of severity of aortic stenosis and its calcification), procedural data, and clinical evolution will be collected. Inflammatory markers will be measured, which along with clinical date will be tested for correlation with microparticle levels.

Patients MPs will be measured before and after percutaneous treatment of the severe aortic stenosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical indication to be treated with transcatheter aortic valve replacement.

排除标准

  • Non native aortic valve
  • Moderate aortic regurgitation
  • The following complications following valve implantation: patient instability, need for vasoactive pressors, sepsis and severe infections, stroke.

结局指标

主要结局

Difference in microparticle levels

时间窗: Day 5

Difference of total microparticle levels before and after treatment of patients with percutaneous aortic valve replacement

次要结局

  • Endothelial microparticle levels(Day 5)
  • Macrophage microparticle levels(Day 5)
  • Platelet microparticle levels(Day 5)

研究者

发起方
InCor Heart Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pedro A. Lemos

Professor of Medicine

InCor Heart Institute

研究点 (2)

Loading locations...

相似试验